WOK
WORK Medical Technology Group LTD
Price Chart
Latest Quote
$0.09
-0.02 (-15.70%)
Current Price
| Previous Close | $0.10 |
| Open | $0.10 |
| Day High | $0.10 |
| Day Low | $0.08 |
| Volume | 59,554,374 |
Stock Information
| Shares Outstanding | 1.22M |
| Total Debt | $6.42M |
| Cash Equivalents | $4.09M |
| Revenue | $9.85M |
| Net Income | $-1.07M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $113K |
| EPS (TTM) | $-400.00 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.26M |
| Sales | $9.85M |
| Income | $-1.07M |
| Book/sh | $17.70 |
| Cash/sh | $3.35 |
| Employees | 238 |
Financial Ratios
| Quick Ratio | 0.39 |
| Current Ratio | 1.71 |
| Debt/Eq | 30.32 |
Returns & Margins
| ROA | -4.49% |
| ROE | -6.45% |
| Gross Margin | 23.81% |
| Operating Margin | -17.52% |
| Profit Margin | -10.89% |
Ownership
| Insider Ownership | 20.05% |
| Institutional Ownership | 0.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.01 |
| P/B | 0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.93 |
| SMA50 | $1.10 |
| SMA200 | $1107.40 |
| RSI | 2.96 |
| ATR | 0.0634 |
| Shares Float | 1.22M |
| Short Float | 37.96% |
| Short Ratio | 0.02 |
| Rel Volume | 0.49 |
Performance History
| Week | -7.45% |
| Month | -93.45% |
| Quarter | -92.16% |
| 6 Months | -99.98% |
| YTD | -96.25% |
| Year | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $0.09 | 60,671,000 |
| 2026-06-04 | $0.10 | 73,082,300 |
| 2026-06-03 | $0.11 | 181,271,900 |
| 2026-06-02 | $0.10 | 105,461,500 |
| 2026-06-01 | $0.11 | 388,311,100 |
| 2026-05-29 | $0.09 | 75,028,300 |
| 2026-05-28 | $0.10 | 60,491,500 |
| 2026-05-27 | $0.10 | 117,168,300 |
| 2026-05-26 | $0.11 | 213,978,500 |
| 2026-05-22 | $0.11 | 120,787,800 |
| 2026-05-21 | $0.16 | 141,840,400 |
| 2026-05-20 | $0.19 | 199,529,000 |
| 2026-05-19 | $0.23 | 66,868,700 |
| 2026-05-18 | $0.38 | 64,746,400 |
| 2026-05-15 | $0.66 | 93,708,500 |
| 2026-05-14 | $1.30 | 55,756,200 |
| 2026-05-13 | $2.76 | 204,186,600 |
| 2026-05-12 | $6.66 | 80,964,600 |
| 2026-05-11 | $3.92 | 152,415,600 |
| 2026-05-08 | $1.28 | 16,600 |
| 2026-05-07 | $1.31 | 15,300 |
| 2026-05-06 | $1.33 | 17,200 |
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
đ° Latest News
WORK Medical Technology Group Is Trending Overnight â Here's Why WOK Stock Surged Over 69% In After-Hours Session
Benzinga âĸ 2026-05-13T05:34:55Z
AI Healthcare and BioToken Partnership Expands WORK Medicalâs (WOK) Digital Asset Ambitions
InvestorsHub âĸ 2026-05-11T15:01:46Z
BC-Most Active Stocks
Associated Press Finance âĸ 2025-12-26T15:30:16ZWORK Medical and Xin Rui Hospital team up for healthcare AI applications
Hospital Management âĸ 2025-09-23T09:36:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $7,503,861 | $8,638,054 | $9,422,967 | $15,292,498 |
| Cost Of Revenue | $7,503,861 | $8,638,054 | $9,422,967 | $15,292,498 |
| Total Revenue | $9,848,715 | $11,506,440 | $13,565,951 | $19,711,290 |
| Operating Revenue | $9,830,220 | $11,410,229 | $13,414,300 | $19,473,564 |
| Expenses | ||||
| Interest Expense | $503,519 | $557,571 | $392,741 | $352,968 |
| Total Expenses | $10,744,248 | $15,205,054 | $13,079,492 | $17,886,321 |
| Other Income Expense | $135,400 | $578,758 | $-8,746 | $-360,409 |
| Other Non Operating Income Expenses | $135,400 | $578,758 | $-8,746 | $-360,409 |
| Net Non Operating Interest Income Expense | $-321,837 | $-545,844 | $-367,324 | $-350,999 |
| Interest Expense Non Operating | $503,519 | $557,571 | $392,741 | $352,968 |
| Operating Expense | $3,240,387 | $6,567,000 | $3,656,525 | $2,593,823 |
| Other Operating Expenses | $-1,600,527 | $-346,571 | $-74,232 | $-1,186,641 |
| Selling And Marketing Expense | $2,078,251 | $2,053,019 | $1,567,385 | $1,032,685 |
| General And Administrative Expense | $2,327,352 | $4,558,041 | $1,861,728 | $2,563,879 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Net Interest Income | $-321,837 | $-545,844 | $-367,324 | $-350,999 |
| Interest Income | $181,682 | $11,727 | $25,417 | $1,969 |
| Normalized Income | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Net Income From Continuing And Discontinued Operation | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Net Income Common Stockholders | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Net Income | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Net Income Including Noncontrolling Interests | $-1,201,023 | $-3,540,409 | $63,383 | $944,126 |
| Net Income Continuous Operations | $-1,201,023 | $-3,540,409 | $63,383 | $944,126 |
| Pretax Income | $-1,081,970 | $-3,665,700 | $110,389 | $1,113,561 |
| Interest Income Non Operating | $181,682 | $11,727 | $25,417 | $1,969 |
| Operating Income | $-895,533 | $-3,698,614 | $486,459 | $1,824,969 |
| Gross Profit | $2,344,854 | $2,868,386 | $4,142,984 | $4,418,792 |
| Special Income Charges | - | - | - | - |
| Per Share | ||||
| Diluted EPS | - | $-2700.00 | $77.26 | $558.20 |
| Basic EPS | - | $-2700.00 | $77.26 | $596.70 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $344,657 | $-1,697,677 | $2,106,259 | $4,724,796 |
| Reconciled Depreciation | $923,108 | $1,410,452 | $1,603,129 | $3,258,267 |
| EBITDA (Bullshit earnings) | $344,657 | $-1,697,677 | $2,106,259 | $4,724,796 |
| EBIT | $-578,451 | $-3,108,129 | $503,130 | $1,466,529 |
| Diluted NI Availto Com Stockholders | $-1,072,667 | $-3,492,318 | $112,030 | $865,210 |
| Minority Interests | $128,356 | $48,091 | $48,647 | $-78,916 |
| Tax Provision | $119,053 | $-125,291 | $47,006 | $169,435 |
| Research And Development | $435,311 | $302,511 | $301,644 | $183,900 |
| Selling General And Administration | $4,405,603 | $6,611,060 | $3,429,113 | $3,596,564 |
| Other Gand A | $2,327,352 | $4,558,041 | $1,861,728 | $2,563,879 |
| Diluted Average Shares | - | $1,293 | $1,450 | $1,550 |
| Basic Average Shares | - | $1,293 | $1,450 | $1,450 |
| Total Unusual Items | - | - | - | - |
| Total Unusual Items Excluding Goodwill | - | - | - | - |
| Impairment Of Capital Assets | - | - | - | - |
| Excise Taxes | - | - | - | - |
Fetched: 2026-06-06
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $17,379,825 | $12,141,864 | $8,877,801 | $9,050,816 |
| Total Assets | $33,156,256 | $36,250,563 | $29,958,901 | $25,541,469 |
| Total Non Current Assets | $12,701,123 | $15,423,343 | $7,806,223 | $8,930,675 |
| Non Current Deferred Assets | $0 | $112,916 | $66,872 | $0 |
| Non Current Deferred Taxes Assets | $0 | $112,916 | $66,872 | $0 |
| Goodwill And Other Intangible Assets | $959,116 | $1,044,062 | $998,450 | $949,955 |
| Other Intangible Assets | $959,116 | $1,044,062 | $998,450 | $949,955 |
| Current Assets | $20,455,133 | $20,827,220 | $22,152,678 | $16,610,794 |
| Other Current Assets | $41,926 | $90,854 | $59,535 | $8,897 |
| Restricted Cash | $0 | $400,000 | $41,187 | $42,244 |
| Prepaid Assets | $1,418,877 | $4,840,633 | $3,493,971 | $4,701,757 |
| Inventory | $2,455,477 | $3,183,951 | $4,620,191 | $4,358,171 |
| Receivables | $12,450,254 | $5,754,177 | $10,985,522 | $6,148,710 |
| Receivables Adjustments Allowances | $0 | $-427,351 | $-352,935 | $-370,746 |
| Loans Receivable | $1,048,086 | $2,508,978 | $4,460,353 | $2,578,346 |
| Accounts Receivable | $615,838 | $1,648,797 | $3,332,322 | $3,287,817 |
| Allowance For Doubtful Accounts Receivable | $-71,529 | $-1,003,799 | $-1,011,601 | $-1,344,480 |
| Gross Accounts Receivable | $687,367 | $2,652,596 | $4,343,923 | $4,632,297 |
| Cash Cash Equivalents And Short Term Investments | $4,088,599 | $6,557,605 | $1,596,096 | $731,178 |
| Cash And Cash Equivalents | $4,088,599 | $6,557,605 | $1,596,096 | $731,178 |
| Current Deferred Assets | - | $0 | $1,356,176 | $619,837 |
| Other Receivables | - | $593,327 | $613,580 | $492,888 |
| Debt | ||||
| Net Debt | $2,302,748 | $6,908,537 | $7,399,929 | $5,483,042 |
| Total Debt | $6,416,846 | $13,466,142 | $9,095,715 | $6,301,313 |
| Long Term Debt And Capital Lease Obligation | $18,756 | $0 | $50,130 | $68,504 |
| Current Debt And Capital Lease Obligation | $6,398,090 | $13,466,142 | $9,045,585 | $6,232,809 |
| Current Debt | $6,391,347 | $13,466,142 | $8,996,025 | $6,214,220 |
| Other Current Borrowings | - | $142,499 | $155,564 | $239,665 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $11,991,525 | $20,180,190 | $18,972,986 | $14,350,869 |
| Total Non Current Liabilities Net Minority Interest | $20,059 | $0 | $50,130 | $94,036 |
| Non Current Deferred Liabilities | $1,303 | - | $0 | $25,532 |
| Non Current Deferred Taxes Liabilities | $1,303 | - | $0 | $25,532 |
| Current Liabilities | $11,971,466 | $20,180,190 | $18,922,856 | $14,256,833 |
| Current Deferred Liabilities | $402,407 | $625,326 | $776,210 | $744,107 |
| Payables And Accrued Expenses | $5,170,969 | $6,088,722 | $9,101,061 | $7,279,917 |
| Payables | $5,170,969 | $6,088,722 | $9,101,061 | $7,279,917 |
| Other Payable | $957,102 | $1,145,240 | $3,009,842 | $1,726,952 |
| Total Tax Payable | $2,476,544 | $2,371,387 | $2,125,344 | $1,723,080 |
| Income Tax Payable | $501,480 | $508,726 | $736,590 | $619,576 |
| Accounts Payable | $1,724,551 | $1,497,152 | $3,961,827 | $3,202,664 |
| Equity | ||||
| Common Stock Equity | $18,338,941 | $13,185,926 | $9,876,251 | $10,000,771 |
| Total Equity Gross Minority Interest | $21,164,731 | $16,070,373 | $10,985,915 | $11,190,600 |
| Stockholders Equity | $18,338,941 | $13,185,926 | $9,876,251 | $10,000,771 |
| Other Equity Interest | $-6,250 | $-6,250 | $-6,250 | $-6,250 |
| Gains Losses Not Affecting Retained Earnings | $291,002 | $491,266 | $210,654 | $410,412 |
| Other Equity Adjustments | $291,002 | $491,266 | $210,654 | $410,412 |
| Retained Earnings | $4,958,991 | $6,076,018 | $9,580,585 | $9,505,347 |
| Other | ||||
| Ordinary Shares Number | $10,359 | $1,459 | $1,450 | $1,450 |
| Share Issued | $10,359 | $1,459 | $1,450 | $1,450 |
| Tangible Book Value | $17,379,825 | $12,141,864 | $8,877,801 | $9,050,816 |
| Invested Capital | $24,730,288 | $26,652,068 | $18,872,276 | $16,214,991 |
| Working Capital | $8,483,667 | $647,030 | $3,229,822 | $2,353,961 |
| Capital Lease Obligations | $25,499 | $0 | $99,690 | $87,093 |
| Total Capitalization | $18,338,941 | $13,185,926 | $9,876,251 | $10,000,771 |
| Minority Interest | $2,825,790 | $2,884,447 | $1,109,664 | $1,189,829 |
| Additional Paid In Capital | $13,043,402 | $6,617,596 | $85,012 | $85,012 |
| Capital Stock | $51,796 | $7,296 | $6,250 | $6,250 |
| Common Stock | $51,796 | $7,296 | $6,250 | $6,250 |
| Long Term Capital Lease Obligation | $18,756 | $0 | $50,130 | $68,504 |
| Current Deferred Revenue | $402,407 | $625,326 | $776,210 | $744,107 |
| Current Capital Lease Obligation | $6,743 | $0 | $49,560 | $18,589 |
| Line Of Credit | $6,391,347 | $13,323,643 | $8,840,461 | $5,974,555 |
| Dueto Related Parties Current | $12,772 | $1,074,943 | $4,048 | $627,221 |
| Net PPE | $11,742,007 | $14,266,365 | $6,740,901 | $7,980,720 |
| Accumulated Depreciation | $-6,837,961 | $-6,273,435 | $-11,147,642 | $-10,732,459 |
| Gross PPE | $18,579,968 | $20,539,800 | $17,888,543 | $18,713,179 |
| Construction In Progress | $1,128,095 | $2,893,880 | $0 | - |
| Other Properties | $26,060 | - | $114,127 | $92,305 |
| Machinery Furniture Equipment | $5,643,663 | $5,729,012 | $12,377,408 | $13,087,620 |
| Buildings And Improvements | $11,782,150 | $11,916,908 | $5,397,008 | $5,533,254 |
| Properties | $0 | $0 | $0 | $5,533,254 |
| Inventories Adjustments Allowances | $-355,043 | $-251,642 | $-241,288 | $-229,239 |
| Finished Goods | $1,404,946 | $1,366,573 | $2,089,383 | $2,210,596 |
| Work In Process | $878,322 | $1,463,866 | $2,030,108 | $1,747,142 |
| Raw Materials | $527,252 | $605,154 | $741,988 | $629,672 |
| Duefrom Related Parties Current | $10,786,330 | $1,430,426 | $2,932,202 | $160,405 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | $508,567 |
Fetched: 2026-06-06
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $4,911,778 | $-11,486,494 | $1,626,432 | $-4,271,494 |
| Operating Activities | ||||
| Operating Cash Flow | $6,244,285 | $-2,228,087 | $2,209,736 | $-2,258,948 |
| Cash Flow From Continuing Operating Activities | $6,244,285 | $-2,228,087 | $2,209,736 | $-2,258,948 |
| Operating Gains Losses | $178,507 | $42,504 | $8,089 | $-10,871 |
| Investing Activities | ||||
| Capital Expenditure | $-1,332,507 | $-9,258,407 | $-583,304 | $-2,012,546 |
| Investing Cash Flow | $-7,607,719 | $-9,064,079 | $-583,304 | $-1,347,165 |
| Cash Flow From Continuing Investing Activities | $-7,607,719 | $-9,064,079 | $-583,304 | $-1,347,165 |
| Net Other Investing Changes | $-6,663,034 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $6,900,912 | $7,373,839 | $0 | $0 |
| Financing Cash Flow | $-898,212 | $15,657,024 | $-728,719 | $3,566,223 |
| Cash Flow From Continuing Financing Activities | $-898,212 | $15,657,024 | $-728,719 | $3,566,223 |
| Net Other Financing Charges | $-2,004,791 | $7,231,077 | $4,535,197 | $13,260,930 |
| Net Common Stock Issuance | $6,900,912 | $7,373,839 | $0 | $0 |
| Common Stock Issuance | $6,900,912 | $7,373,839 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-24,610,052 | $-15,077,148 | $-14,394,560 | $-17,772,116 |
| Issuance Of Debt | $18,815,719 | $16,129,256 | $9,130,644 | $8,077,409 |
| Interest Paid Supplemental Data | $508,519 | $543,753 | $312,035 | $312,282 |
| Income Tax Paid Supplemental Data | $8,103 | $9,973 | $160,162 | $340,024 |
| End Cash Position | $4,088,599 | $6,557,605 | $1,637,283 | $773,422 |
| Beginning Cash Position | $6,557,605 | $1,637,283 | $773,422 | $873,131 |
| Effect Of Exchange Rate Changes | $-207,360 | $555,464 | $-33,852 | $-59,819 |
| Changes In Cash | $-2,261,646 | $4,364,858 | $897,713 | $-39,890 |
| Net Issuance Payments Of Debt | $-5,794,333 | $1,052,108 | $-5,263,916 | $-9,694,707 |
| Net Short Term Debt Issuance | $-6,655,113 | $-548,714 | $-2,563,543 | $-9,493,121 |
| Short Term Debt Payments | $-24,610,052 | $-13,943,492 | $-11,670,625 | $-16,741,488 |
| Short Term Debt Issuance | $17,954,939 | $13,394,778 | $9,107,082 | $7,248,367 |
| Net Long Term Debt Issuance | $860,780 | $1,600,822 | $-2,700,373 | $-201,586 |
| Long Term Debt Payments | $0 | $-1,133,656 | $-2,723,935 | $-1,030,628 |
| Long Term Debt Issuance | $860,780 | $2,734,478 | $23,562 | $829,042 |
| Net Business Purchase And Sale | $-85,107 | $0 | $0 | $63,621 |
| Purchase Of Business | $-85,107 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $0 | $-33,313 | $-127,913 | $0 |
| Purchase Of Intangibles | $0 | $-33,313 | $-127,913 | $0 |
| Net PPE Purchase And Sale | $-859,578 | $-9,030,766 | $-455,391 | $-1,410,786 |
| Sale Of PPE | $472,929 | $194,328 | $0 | $601,760 |
| Purchase Of PPE | $-1,332,507 | $-9,225,094 | $-455,391 | $-2,012,546 |
| Change In Working Capital | $6,441,015 | $-107,509 | $461,845 | $-7,128,134 |
| Change In Other Working Capital | $-1,588,826 | $1,598,954 | $-3,911,832 | $-7,885 |
| Change In Other Current Liabilities | $-5,838 | $-2,029 | $-51,755 | $-5,212 |
| Change In Payables And Accrued Expense | $213,034 | $-4,328,956 | $2,689,463 | $-4,823,816 |
| Change In Accrued Expense | $-32,465 | $-1,524,631 | $1,688,370 | $917,303 |
| Change In Payable | $245,499 | $-2,804,325 | $1,001,093 | $-5,741,119 |
| Change In Account Payable | $245,499 | $-2,553,902 | $864,585 | $-5,822,547 |
| Change In Tax Payable | $0 | $-250,423 | $136,508 | $81,428 |
| Change In Income Tax Payable | $0 | $-250,423 | $136,508 | $81,428 |
| Change In Prepaid Assets | $6,231,422 | $-767,638 | $2,268,463 | $-385,892 |
| Change In Inventory | $568,669 | $1,576,799 | $-400,544 | $2,053,675 |
| Change In Receivables | $1,022,554 | $1,815,361 | $-131,950 | $-3,959,004 |
| Changes In Account Receivables | $1,022,554 | $1,815,361 | $-131,950 | $-3,959,004 |
| Other Non Cash Items | $-158,428 | - | - | - |
| Provisionand Write Offof Assets | $-155,644 | $12,157 | $149,503 | $1,108,999 |
| Asset Impairment Charge | $105,599 | $762 | $18,320 | $-117,327 |
| Deferred Tax | $111,151 | $-46,044 | $-94,533 | $-314,008 |
| Deferred Income Tax | $111,151 | $-46,044 | $-94,533 | $-314,008 |
| Depreciation Amortization Depletion | $923,108 | $1,410,452 | $1,603,129 | $3,258,267 |
| Depreciation And Amortization | $923,108 | $1,410,452 | $1,603,129 | $3,258,267 |
| Gain Loss On Sale Of PPE | $178,381 | $42,504 | $8,089 | $-10,871 |
| Gain Loss On Sale Of Business | $126 | $0 | $0 | - |
| Net Income From Continuing Operations | $-1,201,023 | $-3,540,409 | $63,383 | $944,126 |
| Sale Of Business | - | $0 | $0 | $63,621 |
| Net Investment Purchase And Sale | - | - | - | - |
| Purchase Of Investment | - | - | - | - |
Fetched: 2026-06-06